Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

@article{Kadiri1998ComparisonON,
  title={Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.},
  author={Abdelkrim Kadiri and Abdelmjid Chraibi and Fatima Marouan and M R Ababou and N el Guermai and A Wadjinny and A Kerfati and M Douiri and J D Bensouda and J Belkhadir and Y Arvanitis},
  journal={Diabetes research and clinical practice},
  year={1998},
  volume={41 1},
  pages={15-23}
}
This open, randomised, cross-over study compared the acceptance and safety of NovoPen 3 with that of conventional syringes and vials when initiating insulin treatment in 96 NIDDM patients with secondary failure to oral hypoglycaemic agents. These patients had not previously been treated with insulin. All patients used each insulin administration system for 12 weeks. Group A started therapy using NovoPen 3 and crossed over to syringe/vial administration; Group B started with syringe/vial… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

Similar Papers

Loading similar papers…